TGFB1 and Graves disease: Experimental administration of human recombinant TGF-β (hrTGF-β) to patients with Graves’ disease or to thyroid follicular cell/lymphocyte co-cultures constrains the proliferation of lympho- and monocytes in the periphery as well as of T-cell clones either in the periphery or in the thyroid.